At the news
? BEARISHIMPACT 6/10 6-K filed Jun 26, 2026 at 16:06 ET
Universe Pharmaceuticals (UPC) announced a share purchase agreement to acquire 100% of Best Praise International Limited for $10.75 million, payable in 4,376,552 Class A ordinary shares (a 15% discount to the reference price of $2.89). The target holds five early-stage Chinese patents in age-related diseases, neurodegenerative conditions, and drug delivery. The deal represents massive dilution, the consideration shares are ~7.8x the current outstanding share count of 563,338 (per the most recent 20-F). The acquisition is subject to closing conditions including Nasdaq compliance and patent validity opinions, with closing expected in Q3 2026.
- Acquisition consideration: US$10,751,000 payable entirely in 4,376,552 Class A ordinary shares at an issue price of $2.4565 per share (15% discount to the $2.89 reference price).
- Existing shares outstanding: 563,338 (per FY2025 20-F). The new shares would increase the share count by ~777%.
- Target Best Praise International holds five PRC patents (applications dating 2020-2022) covering nerve damage, drug delivery hydrogels, melanoma, antibacterial compounds, and anthocyanin extraction, all early-stage IP with no disclosed revenue.
- Closing conditions include board/shareholder approvals, SEC/Nasdaq compliance, PRC legal opinion on patent validity, and confirmation of no change of control.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access